antibody-based therapy (Biolojic/Lilly)

N/A

Report date: 2025/03/14 16:37:07

Base Information

Drug Nameantibody-based therapy (Biolojic/Lilly)
Drug Alias Namemultibody-based therapy (Biolojic/Lilly)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiolojic Design Inc
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And CompanyBiolojic Design Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A